Lantheus Holdings, Inc. Income Taxes Receivable, Current
Lantheus Holdings, Inc. (LNTH) had Income Taxes Receivable, Current of $1.17 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Notes
us-gaap:IncomeTaxesReceivable · last filed 2026-08-06
- 2026-06-30: Income Taxes Receivable, Current $1.17M.
- 2026-03-31: Income Taxes Receivable, Current $1.49M.
- 2025-12-31: Income Taxes Receivable, Current $15.39M.
- 2025-09-30: Income Taxes Receivable, Current $31.88M.
| Period end | Income Taxes Receivable, Current |
|---|---|
| 2026-06-30 | $1.17M 10-Q · filed 2026-08-06 |
| 2026-03-31 | $1.49M 10-Q · filed 2026-05-07 |
| 2025-12-31 | $15.39M 10-Q · filed 2026-08-06 |
| 2025-09-30 | $31.88M 10-Q · filed 2025-11-06 |
| 2024-12-31 | $8.18M 10-K · filed 2026-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |